Elaprase (Idursulfase Solution for Infusion) Manufactured by: Shire |
|
|||||||||
| Name | Strength | Quantity | Price | ||||
| Brand | Coming Soon! | 2mg/ml Solution for Infusion | $0.00 | Buy |
All prices in USD
Elaprase (Idursulfase) is an enzyme replacement therapy from Shire Human Genetic Therapies.
Elaprase (Idursulfase) is designed to replace iduronate-2-sulfatase (I2S), the enzyme that is deficient or absent in people with Hunter syndrome.
Elaprase (Idursulfase) is a weekly infusion therapy, which means it is given intravenously (by IV).
Elaprase (Idursulfase) is designed to treat the underlying cause of Hunter syndrome by replacing the iduronate-2-sulfatase (I2S) enzyme which is deficient or absent in people with Hunter syndrome.